Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesPre-MDCDRG 012-tracheostomy-for-face-mouth-and-neck-diagnoses-or-laryngectomy-with-cc
    Ask Trek AI about this page

    Tracheostomy and Laryngectomy with CC: Inpatient Reimbursement Overview

    DRG 012 addresses inpatient stays for tracheostomy related to face, mouth, and neck conditions or for laryngectomy when a Complication or Comorbidity is present. This Diagnosis-Related Group is important for inpatient reimbursement because the Complication or Comorbidity status alters resource intensity and payment relative to lower-severity groupings.

    Customize your policy alerts

    Sign up for drg 012 policy alerts

    Get alerted when payer policies referencing 012 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 012 Overview

    DRG 012 covers inpatient episodes involving tracheostomy for face, mouth, and neck diagnoses or laryngectomy when a Complication or Comorbidity is present. This Diagnosis-Related Group encompasses procedures for airway management and surgical resection of laryngeal structures associated with significant head and neck pathology. It is important for Medicare payment because the presence of a Complication or Comorbidity elevates relative resource use and affects the Diagnosis-Related Group assignment and resulting reimbursement. Accurate clinical documentation and coding determine whether an encounter is classified in this Diagnosis-Related Group and therefore influence inpatient payment.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute airway management intervention trials: randomized or prospective cohort studies evaluating techniques and timing for tracheostomy placement or variation in surgical approach in patients with head, neck, or laryngeal disease (for example emergent tracheostomy versus planned tracheostomy during hospitalization for obstructing tumors or after laryngectomy). These studies focus on patients admitted for face, mouth, neck diagnoses or laryngeal cancer who require definitive airway procedures and examine perioperative complications, time to decannulation, ventilator days, and short-term mortality. Findings inform clinicians about best practices to reduce in-hospital complications and inform payers about resource utilization associated with different acute airway strategies.
    • Comparative effectiveness and perioperative care pathway studies: trials comparing anesthesia protocols, perioperative antibiotic stewardship, wound care approaches, or enhanced recovery pathways for patients undergoing tracheostomy or laryngectomy with significant comorbidity (CC-level illness). These studies enroll medically complex inpatients—often older adults or those with cardiopulmonary comorbidities—evaluating length of stay, readmission rates, surgical site infection, and need for ICU resources. Results guide providers on optimizing perioperative care to improve outcomes and help payers anticipate cost drivers related to complications and prolonged hospitalization.
    • Post-discharge functional outcomes and rehabilitation research: prospective observational studies or randomized trials testing swallowing rehabilitation, speech restoration methods, or home-care models for patients after tracheostomy decannulation or laryngectomy, including measurement of quality of life, feeding status, voice rehabilitation success, and long-term healthcare utilization. These studies target survivors transitioning out of acute care who face long-term functional impairment, tracheostomy care needs, and potential for recurrent hospital use. Evidence from these studies is relevant to providers planning multidisciplinary follow-up and to payers evaluating post-acute care coverage, durable medical equipment needs, and programs that may reduce rehospitalization.

    Related Codes

    001-HEART-TRANSPLANT-OR-IMPLANT-OF-HEART-ASSIST-SYSTEM-WITH-MCC

    Heart Transplant or Implant of Heart Assist System with MCC: Inpatient Reimbursement Overview

    002-HEART-TRANSPLANT-OR-IMPLANT-OF-HEART-ASSIST-SYSTEM-WITHOUT-MCC

    Heart Transplant or Implant of Heart Assist System without MCC: Inpatient Reimbursement Overview

    003-ECMO-OR-TRACHEOSTOMY-WITH-MV-96-HOURS-OR-PRINCIPAL-DIAGNOSIS-EXCEPT-FACE-MOUTH-AND-NECK-WITH-MAJOR-O-R-PROCEDURES

    ECMO or Tracheostomy with MV >96 Hours: Inpatient Reimbursement Overview

    004-TRACHEOSTOMY-WITH-MV-96-HOURS-OR-PRINCIPAL-DIAGNOSIS-EXCEPT-FACE-MOUTH-AND-NECK-WITHOUT-MAJOR-O-R-PROCEDURES

    Tracheostomy with Mechanical Ventilation >96 Hours: Inpatient Reimbursement Overview

    005-LIVER-TRANSPLANT-WITH-MCC-OR-INTESTINAL-TRANSPLANT

    Liver Transplant with MCC or Intestinal Transplant: Inpatient Reimbursement Overview

    006-LIVER-TRANSPLANT-WITHOUT-MCC

    Liver Transplant without Major Complication or Comorbidity: Inpatient Reimbursement Overview

    007-LUNG-TRANSPLANT

    Lung Transplant: Inpatient Reimbursement Overview

    008-SIMULTANEOUS-PANCREAS-AND-KIDNEY-TRANSPLANT

    Simultaneous Pancreas and Kidney Transplant: Inpatient Reimbursement Overview

    010-PANCREAS-TRANSPLANT

    Pancreas Transplant: Inpatient Reimbursement Overview

    011-TRACHEOSTOMY-FOR-FACE-MOUTH-AND-NECK-DIAGNOSES-OR-LARYNGECTOMY-WITH-MCC

    Tracheostomy/Laryngectomy with MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 16

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.